Pfizer Says Vulnerable Groups To Get Vaccine First

Dr. Scott Gottlieb discusses the timeline for vaccine availability, with emergency use authorization expected for a limited population this winter. Older adults will be prioritized, with broader availability in the spring. Pfizer and Biontech have requested FDA emergency use authorization for their vaccine, which has shown 95% efficacy.

When is the vaccine expected to be licensed for general use?

• Third quarter

• Second quarter

• Fourth quarter

• First quarter

Who is Dr. Scott Gottlieb?

• A board member for Moderna

• A scientist at Biontech

• A current FDA Commissioner

• A former Commissioner of the USDA

Which group is prioritized to receive the vaccine first?

• Teachers

• Older adults

• Children

• Healthcare workers

What is the expected effectiveness of the Pfizer and Biontech vaccine?

• 85%

• 90%

• 95%

• 99%

What did Pfizer and Biontech request from the FDA?

• Full approval

• Emergency use authorization

• Clinical trial extension

• Vaccine recall